Lobbying Information
Subject Matters
- Government Procurement
- Health
- Industry
- Science and Technology
Subject Matter Details
Policies or Program
- Canada’s Strategic Innovation Fund, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a focus of the government’s post-COVID recovery plan.
- Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the Biomanufacturing and Life Sciences Strategy with a focus on the importance of vaccines for public health in Canada.
- Policies regarding the availability of Novavax's COVID-19 vaccine throughout Canada.
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Canada Economic Development for Quebec Regions
-
Canadian Institutes of Health Research (CIHR)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
National Research Council (NRC)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Public Services and Procurement Canada (PSPC)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
21 Firstfield Road
Gaithersburg, MD 20878
United States of America
Telephone number:
202-661-7946
Web address:
https://ca.novavax.com/
Client representative
Kelly Cappio, Vice President, Policy & Government Affairs
Parent Company Information
Novavax Inc. / Novavax Inc. is not a subsidiary of any other parent companies.
Coalition Members Information
Novavax Inc. / Novavax Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Novavax Inc. / Novavax Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Novavax Inc. / Novavax Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
WILLIAM DEMPSTER
|
Public offices held
Business address:
150 Metcalfe Street
Suite 604
OTTAWA, ON K2P 1P1
Canada
Telephone number:
613-614-0283
Fax number:
613-249-3645
Consultant Firm and Address
Firm:
3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.
Address:
150 Metcalfe Street
Suite 604
Ottawa, ON K2P 1P1
Canada
Telephone number:
613-800-8340
Fax number:
613-800-8343
